In this multicenter retrospective study of Chinese patients with moderate to severe obesity, most (92.7%) patients attained successful weight loss (defined as EWL >50%) at 12 months after metabolic surgery, accompanied by remarkable improvements in blood pressure, glucolipid metabolism, insulin resistance, liver function, and serum levels of uric acid and inflammatory biomarkers. This evidence concerns the gene INS and obesity disorder.